Ranbaxy Consumers Denied Cert. In Drug Contamination Suit
A New Jersey federal judge Wednesday denied class certification in a suit claiming Ranbaxy Pharmaceuticals Inc. distributed pills that might have contained glass, saying there was not enough data to identify...To view the full article, register now.
Already a subscriber? Click here to view full article